T1	Person 0 4	Male
T2	Person 8 14	female
*	OR T2 T1
T3	Value 15 24	= 2 years
T4	Person 28 31	age
R1	Has_value Arg1:T4 Arg2:T3	
T5	Condition 39 58	sickle cell disease
T6	Procedure 73 91	Hb electrophoresis
T7	Procedure 95 114	more specific tests
*	OR T6 T7
T8	Scope 73 114	Hb electrophoresis or more specific tests
R2	Has_scope Arg1:T5 Arg2:T8	
T10	Condition 119 154	other conditions with iron overload
T9	Multiplier 160 168	repeated
T11	Procedure 169 187	blood transfusions
R3	Has_multiplier Arg1:T11 Arg2:T9	
R4	AND Arg1:T10 Arg2:T11	
*	OR T5 T10
T12	Measurement 230 242	Baseline LIC
T13	Value 243 250	>7 mg/g
R5	Has_value Arg1:T12 Arg2:T13	
T14	Procedure 267 270	MRI
R6	AND Arg1:T12 Arg2:T14	
T15	Multiplier 301 316	no less than 20
T16	Procedure 317 337	transfusions of RBCs
R7	Has_multiplier Arg1:T16 Arg2:T15	
T17	Multiplier 367 377;390 398	at least 1 per year
T18	Temporal 399 418	in the last 2 years
T19	Procedure 378 389	transfusion
R8	Has_multiplier Arg1:T19 Arg2:T17	
R9	Has_temporal Arg1:T19 Arg2:T18	
T20	Condition 431 472	expected to have a continuing requirement
T21	Temporal 509 541	during the duration of the trial
R10	Has_temporal Arg1:T20 Arg2:T21	
